Proskauer advised ARCH Venture Partners on the transaction. ARCH Venture Partners (“ARCH”) announced the closing of ARCH Venture Fund XII. The fund closed with $2.975 billion...
ARCH Venture Fund XII’s $2.975 Billion Fundraising
Third Rock Ventures’ $1.1 Billion Fundraising
Proskauer advised Third Rock Ventures on the deal. Third Rock Ventures, a leading health care venture firm, announced the closing of its sixth fund, which raised...
Havencrest Healthcare Partners II’s $356 Million Fundraising
Proskauer advised Havencrest Capital Management on the deal. Havencrest Capital Management, a Dallas-based lower middle-market private equity investment firm specializing in the health care industry, announced...
G Square’s €500 Million Fundraising
Debevoise & Plimpton has advised Adams Street Partners on the deal, while Proskauer has advised G Square Healthcare Private Equity. Stephenson Harwood advised Schroders Capital. G...
Atlas Venture’s $450 Million Fundraising
Proskauer advised Atlas Venture on the deal. Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, announced the closing of its thirteenth...
Blossom III’s $432 Million Fundraising
Proskauer advised Blossom Capital on the formation of Blossom III. The fund raised $432 million to invest in early-stage technology startups in Europe. Blossom Capital has...
7RIDGE’s Acquisition of Trading Technologies International
Proskauer has advised 7RIDGE on the deal. WongPartnership advised Singapore Exchange Limited. 7RIDGE, a Guernsey-based private equity investing partnership, executed its acquisition of Trading Technologies International,...
Ares Private Credit Solutions II’s $5 Billion Fundraising
Proskauer advised Ares Management on the deal. Ares Management, a leading global alternative investment manager, announced the final closing of Ares Private Credit Solutions II, L.P....
RA Capital Nexus Fund III’s $880 Million Fundraising
Proskauer advised RA Capital Management on the deal. RA Capital Management, LP, a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and...
Flagship Pioneering’s $3.4 Billion Fund VII Closing
Proskauer advised Flagship Pioneering on the transaction. Flagship Pioneering, which conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability, completed the...
Perceptive Xontogeny Venture Fund II’s $515 Million Fundraising
Proskauer advised Perceptive Advisors on the deal. Perceptive Advisors completed the first and final closing of Perceptive Xontogeny Venture Fund II, LP (“PXV Fund II”) with $515...
Atlas Capital Resources IV’s $3.1 Billion Fundraising
Proskauer advised Atlas Holdings LLC on the deal. Atlas Holdings LLC completed the first and final close of its fourth private equity investment fund, Atlas Capital Resources...